Carbon nanotube nano-therapy composites with paclitaxel
AssigneeMolecular Rebar Design, LLC
InventorsKurt W. Swogger, Clive P. Bosnyak, Nancy Henderson, Paul Everill
Life of this patent
Estimating the term…
Loading patent…
AssigneeMolecular Rebar Design, LLC
InventorsKurt W. Swogger, Clive P. Bosnyak, Nancy Henderson, Paul Everill
Estimating the term…
In various embodiments a payload molecule or drug molecule delivery system is disclosed for delivering paclitaxel. The system comprises a plurality of functionalized discrete carbon nanotubes having specific properties. The composition can comprise a plurality of discrete carbon nanotubes that have at least a portion of the carbon nanotubes with a number average (ratio of number average contour length to end to end length) of greater than 1.1 and up to about 3. These discrete carbon nanotubes having the specified ratio of number average (tube contour length (TCL) to number average tube end-end length (TEE)) ratio are not only discrete (separated) from one another, but are also controlled in their alignment such that processability and mechanical strength properties are both enhanced. Utility of the molecular rebar composition includes, but is not limited to improved payload molecule delivery, such as drug delivery, into body of an animal, such as human.
A composition comprising:
In a payload molecule delivery system composition comprising carbon nanotubes and at least one payload molecule, wherein the payload molecule comprises paclitaxel, the improvement comprising using functionalized discrete carbon nanotubes, wherein the functionalized discrete carbon nanotubes are aqueous-dispersible, having an innermost wall and an outermost wall, the inner-most wall defining an interior cavity;
Dependencies are inferred from the claim text.